The Iluka Resources Ltd (ASX: ILU) share price has climbed 31% in the last three months and 5% just yesterday – is it a buy?
Iluka is a resources and mining company focused on minerals zircon, rutile and synthetic rutile which are used in ceramics, pigments and optical equipment, among other uses. Headquartered in Perth, Iluka has been operating for over 60 years, and currently operates in Australia and Sierra Leone.
Since the beginning of 2019, Iluka shares have risen about 31%. This has been helped along by a positive quarterly report showing an increase in revenue of 29% despite falling sales. This was largely the result of higher zircon and rutile prices.
However, Iluka shares are actually down over the six-month period by 5.3%. The current share price of $9.47 is still down from $10.14 six months ago. Although Iluka shares have performed well over the last three months, they actually show negative results over the six-month, one-year and five-year periods.
Iluka currently offers a dividend yield of 3.2%, but this hasn’t been consistent over the listed life of the company.
From around 1999 to 2007, dividend distributions were very reliable at approximately 22 cents per share (cps). Since then, dividends have been up and down, mostly following the share price. In 2011, they paid 28cps, then 80cps in 2012 followed by 15cps in 2013. They paid 35cps in 2018 and just 6cps in 2017. There are definitely better options for dividend income.
In their full-year 2018 report, Iluka reported underlying group EBITDA of $600 million, up 67% year-on-year. They also reported operating cash flow of $594 million and free cash flow of $304 million. This might signal that the dividends are going to be more stable over the coming years.
While the recent capital gains may seem tempting, this is a resources company and is always going to be subject to commodity prices and supply/demand. In 2019, Iluka has forecast lower sales of zircon and synthetic rutile, so its 2019 results may be noticeably lower than in 2018.
If you’re looking for stable dividend income, there are better options than Iluka. And if you’re looking for capital gains, you might be better off with the growth shares in the free report below…
After searching through a market with over 2,000 shares, our lead expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).
Disclaimer: At the time of writing, Max does not own shares in any of the companies mentioned.